# Product Vision: BIOMAX AI v2.0

**Ğ’ĞµÑ€ÑĞ¸Ñ:** 1.0  
**Ğ”Ğ°Ñ‚Ğ°:** 2026-01-26  
**ĞĞ²Ñ‚Ğ¾Ñ€:** Product Agent  
**Ğ¡Ñ‚Ğ°Ñ‚ÑƒÑ:** Draft â†’ Review

---

## Executive Summary

BIOMAX AI â€” ÑÑ‚Ğ¾ **Personal Health Operating System**, Ğ¼ÑƒĞ»ÑŒÑ‚Ğ¸Ğ°Ğ³ĞµĞ½Ñ‚Ğ½Ğ°Ñ AI-Ğ¿Ğ»Ğ°Ñ‚Ñ„Ğ¾Ñ€Ğ¼Ğ° Ğ´Ğ»Ñ ÑƒĞ¿Ñ€Ğ°Ğ²Ğ»ĞµĞ½Ğ¸Ñ Ğ·Ğ´Ğ¾Ñ€Ğ¾Ğ²ÑŒĞµĞ¼ Ğ¸ Ğ±Ğ¸Ğ¾Ñ…Ğ°ĞºĞ¸Ğ½Ğ³Ğ°. ĞŸĞ»Ğ°Ñ‚Ñ„Ğ¾Ñ€Ğ¼Ğ° Ğ¾Ğ±ÑŠĞµĞ´Ğ¸Ğ½ÑĞµÑ‚ Ğ²ÑĞµ ĞºĞ°Ñ‚ĞµĞ³Ğ¾Ñ€Ğ¸Ğ¸ Ğ¾Ğ¿Ñ‚Ğ¸Ğ¼Ğ¸Ğ·Ğ°Ñ†Ğ¸Ğ¸ Ğ·Ğ´Ğ¾Ñ€Ğ¾Ğ²ÑŒÑ Ğ² ĞµĞ´Ğ¸Ğ½ÑƒÑ ÑĞºĞ¾ÑĞ¸ÑÑ‚ĞµĞ¼Ñƒ Ñ Ğ¿ĞµÑ€ÑĞ¾Ğ½Ğ°Ğ»Ğ¸Ğ·Ğ¸Ñ€Ğ¾Ğ²Ğ°Ğ½Ğ½Ñ‹Ğ¼Ğ¸ Ñ€ĞµĞºĞ¾Ğ¼ĞµĞ½Ğ´Ğ°Ñ†Ğ¸ÑĞ¼Ğ¸ Ğ½Ğ° Ğ¾ÑĞ½Ğ¾Ğ²Ğµ Ğ³ĞµĞ½ĞµÑ‚Ğ¸ĞºĞ¸, Ğ±Ğ¸Ğ¾Ğ¼Ğ°Ñ€ĞºĞµÑ€Ğ¾Ğ² Ğ¸ Ğ´Ğ°Ğ½Ğ½Ñ‹Ñ… Ñ ÑƒÑÑ‚Ñ€Ğ¾Ğ¹ÑÑ‚Ğ².

---

## Problem Statement

### Ğ¢ĞµĞºÑƒÑ‰ĞµĞµ ÑĞ¾ÑÑ‚Ğ¾ÑĞ½Ğ¸Ğµ Ñ€Ñ‹Ğ½ĞºĞ°

Ğ¡ÑƒÑ‰ĞµÑÑ‚Ğ²ÑƒÑÑ‰Ğ¸Ğµ Ñ€ĞµÑˆĞµĞ½Ğ¸Ñ Ğ´Ğ»Ñ ÑƒĞ¿Ñ€Ğ°Ğ²Ğ»ĞµĞ½Ğ¸Ñ Ğ·Ğ´Ğ¾Ñ€Ğ¾Ğ²ÑŒĞµĞ¼ ÑÑ‚Ñ€Ğ°Ğ´Ğ°ÑÑ‚ Ğ¾Ñ‚ Ñ„ÑƒĞ½Ğ´Ğ°Ğ¼ĞµĞ½Ñ‚Ğ°Ğ»ÑŒĞ½Ñ‹Ñ… Ğ¾Ğ³Ñ€Ğ°Ğ½Ğ¸Ñ‡ĞµĞ½Ğ¸Ğ¹:

| ĞŸÑ€Ğ¾Ğ±Ğ»ĞµĞ¼Ğ° | ĞĞ¿Ğ¸ÑĞ°Ğ½Ğ¸Ğµ | Ğ’Ğ»Ğ¸ÑĞ½Ğ¸Ğµ Ğ½Ğ° Ğ¿Ğ¾Ğ»ÑŒĞ·Ğ¾Ğ²Ğ°Ñ‚ĞµĞ»Ñ |
|----------|----------|-------------------------|
| **Ğ¤Ñ€Ğ°Ğ³Ğ¼ĞµĞ½Ñ‚Ğ°Ñ†Ğ¸Ñ** | Ğ ĞµÑˆĞµĞ½Ğ¸Ñ Ñ„Ğ¾ĞºÑƒÑĞ¸Ñ€ÑƒÑÑ‚ÑÑ Ğ½Ğ° Ğ¾Ñ‚Ğ´ĞµĞ»ÑŒĞ½Ñ‹Ñ… Ğ°ÑĞ¿ĞµĞºÑ‚Ğ°Ñ… (Ñ„Ğ¸Ñ‚Ğ½ĞµÑ OR Ğ¿Ğ¸Ñ‚Ğ°Ğ½Ğ¸Ğµ OR ÑĞ¾Ğ½) | ĞĞµĞ²Ğ¾Ğ·Ğ¼Ğ¾Ğ¶Ğ½Ğ¾ Ğ²Ğ¸Ğ´ĞµÑ‚ÑŒ Ñ†ĞµĞ»Ğ¾ÑÑ‚Ğ½ÑƒÑ ĞºĞ°Ñ€Ñ‚Ğ¸Ğ½Ñƒ Ğ·Ğ´Ğ¾Ñ€Ğ¾Ğ²ÑŒÑ |
| **ĞÑ‚ÑÑƒÑ‚ÑÑ‚Ğ²Ğ¸Ğµ Ğ¿ĞµÑ€ÑĞ¾Ğ½Ğ°Ğ»Ğ¸Ğ·Ğ°Ñ†Ğ¸Ğ¸** | Ğ ĞµĞºĞ¾Ğ¼ĞµĞ½Ğ´Ğ°Ñ†Ğ¸Ğ¸ Ğ½Ğµ ÑƒÑ‡Ğ¸Ñ‚Ñ‹Ğ²Ğ°ÑÑ‚ Ğ³ĞµĞ½ĞµÑ‚Ğ¸ĞºÑƒ, Ğ±Ğ¸Ğ¾Ğ¼Ğ°Ñ€ĞºĞµÑ€Ñ‹, Ğ¸Ğ½Ğ´Ğ¸Ğ²Ğ¸Ğ´ÑƒĞ°Ğ»ÑŒĞ½Ñ‹Ğµ Ñ†ĞµĞ»Ğ¸ | "ĞĞ´Ğ½Ğ° Ñ‚Ğ°Ğ±Ğ»ĞµÑ‚ĞºĞ° Ğ´Ğ»Ñ Ğ²ÑĞµÑ…" Ğ½Ğµ Ñ€Ğ°Ğ±Ğ¾Ñ‚Ğ°ĞµÑ‚ |
| **Ğ—Ğ°ĞºÑ€Ñ‹Ñ‚Ñ‹Ğµ ÑĞºĞ¾ÑĞ¸ÑÑ‚ĞµĞ¼Ñ‹** | ĞŸĞ¾Ğ»ÑŒĞ·Ğ¾Ğ²Ğ°Ñ‚ĞµĞ»Ğ¸ Ğ½Ğµ Ğ¼Ğ¾Ğ³ÑƒÑ‚ Ğ´Ğ¾Ğ±Ğ°Ğ²Ğ»ÑÑ‚ÑŒ ÑĞ²Ğ¾Ğ¸ Ğ¿Ñ€Ğ¾Ñ‚Ğ¾ĞºĞ¾Ğ»Ñ‹ Ğ¸ Ğ¸ÑÑĞ»ĞµĞ´Ğ¾Ğ²Ğ°Ğ½Ğ¸Ñ | ĞĞµÑ‚ Ğ²Ğ¾Ğ·Ğ¼Ğ¾Ğ¶Ğ½Ğ¾ÑÑ‚Ğ¸ Ğ¸ÑĞ¿Ğ¾Ğ»ÑŒĞ·Ğ¾Ğ²Ğ°Ñ‚ÑŒ Ğ°Ğ²Ñ‚Ğ¾Ñ€ÑĞºĞ¸Ğµ Ğ¼ĞµÑ‚Ğ¾Ğ´Ğ¸ĞºĞ¸ |
| **ĞĞµĞ´Ğ¾ÑÑ‚Ğ°Ñ‚Ğ¾Ğº Ğ½Ğ°ÑƒÑ‡Ğ½Ğ¾Ğ¹ ÑÑ‚Ñ€Ğ¾Ğ³Ğ¾ÑÑ‚Ğ¸** | Ğ ĞµĞºĞ¾Ğ¼ĞµĞ½Ğ´Ğ°Ñ†Ğ¸Ğ¸ Ğ±ĞµĞ· ÑÑÑ‹Ğ»Ğ¾Ğº Ğ½Ğ° Ğ¸ÑÑ‚Ğ¾Ñ‡Ğ½Ğ¸ĞºĞ¸ Ğ¸ ÑƒÑ€Ğ¾Ğ²Ğ½Ğ¸ Ğ´Ğ¾ĞºĞ°Ğ·Ğ°Ñ‚ĞµĞ»ÑŒĞ½Ğ¾ÑÑ‚Ğ¸ | ĞĞµĞ²Ğ¾Ğ·Ğ¼Ğ¾Ğ¶Ğ½Ğ¾ Ğ¾Ñ†ĞµĞ½Ğ¸Ñ‚ÑŒ Ğ½Ğ°Ğ´Ñ‘Ğ¶Ğ½Ğ¾ÑÑ‚ÑŒ ÑĞ¾Ğ²ĞµÑ‚Ğ° |
| **Ğ Ğ°Ğ·Ñ€Ğ¾Ğ·Ğ½ĞµĞ½Ğ½Ñ‹Ğµ Ğ´Ğ°Ğ½Ğ½Ñ‹Ğµ** | Ğ”Ğ°Ğ½Ğ½Ñ‹Ğµ Ñ Ñ€Ğ°Ğ·Ğ½Ñ‹Ñ… ÑƒÑÑ‚Ñ€Ğ¾Ğ¹ÑÑ‚Ğ² Ğ½Ğµ Ğ¸Ğ½Ñ‚ĞµĞ³Ñ€Ğ¸Ñ€ÑƒÑÑ‚ÑÑ | ĞŸĞ¾Ğ»ÑŒĞ·Ğ¾Ğ²Ğ°Ñ‚ĞµĞ»ÑŒ Ğ²Ñ€ÑƒÑ‡Ğ½ÑƒÑ ÑĞ¾ĞµĞ´Ğ¸Ğ½ÑĞµÑ‚ Ğ¸Ğ½Ñ„Ğ¾Ñ€Ğ¼Ğ°Ñ†Ğ¸Ñ |

### Ğ‘Ğ¾Ğ»ÑŒ Ğ¿Ğ¾Ğ»ÑŒĞ·Ğ¾Ğ²Ğ°Ñ‚ĞµĞ»Ñ (Jobs-to-be-Done)

> *"Ğ¯ Ğ¸ÑĞ¿Ğ¾Ğ»ÑŒĞ·ÑƒÑ 5+ Ğ¿Ñ€Ğ¸Ğ»Ğ¾Ğ¶ĞµĞ½Ğ¸Ğ¹ (Oura, MyFitnessPal, Cronometer, Zero, Headspace), Ñ‚Ñ€Ğ°Ñ‡Ñƒ Ñ‡Ğ°ÑÑ‹ Ğ½Ğ° ÑĞ²ĞµĞ´ĞµĞ½Ğ¸Ğµ Ğ´Ğ°Ğ½Ğ½Ñ‹Ñ… Ğ² Excel, Ğ¸ Ğ²ÑÑ‘ Ñ€Ğ°Ğ²Ğ½Ğ¾ Ğ½Ğµ Ğ¿Ğ¾Ğ½Ğ¸Ğ¼Ğ°Ñ, Ñ€Ğ°Ğ±Ğ¾Ñ‚Ğ°ĞµÑ‚ Ğ»Ğ¸ Ğ¼Ğ¾Ğ¹ Ğ¿Ñ€Ğ¾Ñ‚Ğ¾ĞºĞ¾Ğ» NMN Ğ¸Ğ»Ğ¸ Ğ½ĞµÑ‚. ĞœĞ½Ğµ Ğ½ÑƒĞ¶ĞµĞ½ Ğ¾Ğ´Ğ¸Ğ½ Ğ¸ÑÑ‚Ğ¾Ñ‡Ğ½Ğ¸Ğº Ğ¿Ñ€Ğ°Ğ²Ğ´Ñ‹."*
> 
> â€” Ğ¢Ğ¸Ğ¿Ğ¸Ñ‡Ğ½Ñ‹Ğ¹ Ğ¿Ñ€Ğ¾Ğ´Ğ²Ğ¸Ğ½ÑƒÑ‚Ñ‹Ğ¹ Ğ±Ğ¸Ğ¾Ñ…Ğ°ĞºĞµÑ€

### ĞšĞ»ÑÑ‡ĞµĞ²Ñ‹Ğµ Ğ½ĞµÑ€ĞµÑˆÑ‘Ğ½Ğ½Ñ‹Ğµ Ğ¿Ñ€Ğ¾Ğ±Ğ»ĞµĞ¼Ñ‹

1. **ĞĞµÑ‚ ĞµĞ´Ğ¸Ğ½Ğ¾Ğ¹ Ğ¿Ğ»Ğ°Ñ‚Ñ„Ğ¾Ñ€Ğ¼Ñ‹**, Ğ¾Ğ±ÑŠĞµĞ´Ğ¸Ğ½ÑÑÑ‰ĞµĞ¹ Ğ’Ğ¡Ğ• ĞºĞ°Ñ‚ĞµĞ³Ğ¾Ñ€Ğ¸Ğ¸ Ğ±Ğ¸Ğ¾Ñ…Ğ°ĞºĞ¸Ğ½Ğ³Ğ°
2. **ĞÑ‚ÑÑƒÑ‚ÑÑ‚Ğ²ÑƒĞµÑ‚ Ğ¿Ñ€Ğ¸Ñ‡Ğ¸Ğ½Ğ½Ğ¾-ÑĞ»ĞµĞ´ÑÑ‚Ğ²ĞµĞ½Ğ½Ñ‹Ğ¹ Ğ°Ğ½Ğ°Ğ»Ğ¸Ğ·** Ğ¼ĞµĞ¶Ğ´Ñƒ Ğ¸Ğ½Ñ‚ĞµÑ€Ğ²ĞµĞ½Ñ†Ğ¸ÑĞ¼Ğ¸ Ğ¸ Ñ€ĞµĞ·ÑƒĞ»ÑŒÑ‚Ğ°Ñ‚Ğ°Ğ¼Ğ¸
3. **ĞĞµÑ‚ Ğ¸Ğ½ÑÑ‚Ñ€ÑƒĞ¼ĞµĞ½Ñ‚Ğ¾Ğ² Ğ´Ğ»Ñ N=1 ÑĞºÑĞ¿ĞµÑ€Ğ¸Ğ¼ĞµĞ½Ñ‚Ğ¾Ğ²** Ñ Ğ½Ğ°ÑƒÑ‡Ğ½Ñ‹Ğ¼ Ğ¿Ğ¾Ğ´Ñ…Ğ¾Ğ´Ğ¾Ğ¼
4. **ĞĞµĞ²Ğ¾Ğ·Ğ¼Ğ¾Ğ¶Ğ½Ğ¾ ÑĞ¾Ğ·Ğ´Ğ°Ñ‚ÑŒ Ğ¿ĞµÑ€ÑĞ¾Ğ½Ğ°Ğ»ÑŒĞ½ÑƒÑ Ğ±Ğ°Ğ·Ñƒ Ğ·Ğ½Ğ°Ğ½Ğ¸Ğ¹** Ñ ÑĞ¾Ğ±ÑÑ‚Ğ²ĞµĞ½Ğ½Ñ‹Ğ¼Ğ¸ Ğ¿Ñ€Ğ¾Ñ‚Ğ¾ĞºĞ¾Ğ»Ğ°Ğ¼Ğ¸
5. **ĞĞµÑ‚ AI-ĞºĞ¾ÑƒÑ‡Ğ°**, ĞºĞ¾Ñ‚Ğ¾Ñ€Ñ‹Ğ¹ Ğ·Ğ½Ğ°ĞµÑ‚ Ğ’Ğ¡Ğ® Ğ¸ÑÑ‚Ğ¾Ñ€Ğ¸Ñ Ğ¸ ĞºĞ¾Ğ½Ñ‚ĞµĞºÑÑ‚ Ğ¿Ğ¾Ğ»ÑŒĞ·Ğ¾Ğ²Ğ°Ñ‚ĞµĞ»Ñ

---

## Vision Statement

> **BIOMAX AI â€” Ğ¾Ğ¿ĞµÑ€Ğ°Ñ†Ğ¸Ğ¾Ğ½Ğ½Ğ°Ñ ÑĞ¸ÑÑ‚ĞµĞ¼Ğ° Ğ´Ğ»Ñ Ğ·Ğ´Ğ¾Ñ€Ğ¾Ğ²ÑŒÑ, ĞºĞ¾Ñ‚Ğ¾Ñ€Ğ°Ñ Ñ€Ğ°ÑÑ‚Ñ‘Ñ‚ Ğ²Ğ¼ĞµÑÑ‚Ğµ Ñ Ğ¿Ğ¾Ğ»ÑŒĞ·Ğ¾Ğ²Ğ°Ñ‚ĞµĞ»ĞµĞ¼, Ğ°Ğ´Ğ°Ğ¿Ñ‚Ğ¸Ñ€ÑƒĞµÑ‚ÑÑ Ğ¿Ğ¾Ğ´ ĞµĞ³Ğ¾ Ñ†ĞµĞ»Ğ¸ Ğ¸ Ğ½Ğ°ĞºĞ°Ğ¿Ğ»Ğ¸Ğ²Ğ°ĞµÑ‚ Ğ¿ĞµÑ€ÑĞ¾Ğ½Ğ°Ğ»Ğ¸Ğ·Ğ¸Ñ€Ğ¾Ğ²Ğ°Ğ½Ğ½Ñ‹Ğµ Ğ·Ğ½Ğ°Ğ½Ğ¸Ñ.**

### ĞœĞµÑ‚Ğ°Ñ„Ğ¾Ñ€Ğ° Ğ¿Ñ€Ğ¾Ğ´ÑƒĞºÑ‚Ğ°

ĞšĞ°Ğº **iOS Ğ´Ğ»Ñ Ğ·Ğ´Ğ¾Ñ€Ğ¾Ğ²ÑŒÑ**:
- Ğ¯Ğ´Ñ€Ğ¾ (Health Score) + ĞŸÑ€Ğ¸Ğ»Ğ¾Ğ¶ĞµĞ½Ğ¸Ñ (AI-Ğ°Ğ³ĞµĞ½Ñ‚Ñ‹)
- Ğ¤Ğ°Ğ¹Ğ»Ğ¾Ğ²Ğ°Ñ ÑĞ¸ÑÑ‚ĞµĞ¼Ğ° (Custom RAG Ñ Ğ¿Ñ€Ğ¾Ñ‚Ğ¾ĞºĞ¾Ğ»Ğ°Ğ¼Ğ¸)
- Ğ˜Ğ½Ñ‚ĞµĞ³Ñ€Ğ°Ñ†Ğ¸Ğ¸ (100+ API Ğº ÑƒÑÑ‚Ñ€Ğ¾Ğ¹ÑÑ‚Ğ²Ğ°Ğ¼)
- ĞŸĞµÑ€ÑĞ¾Ğ½Ğ°Ğ»Ğ¸Ğ·Ğ°Ñ†Ğ¸Ñ (Ğ³ĞµĞ½ĞµÑ‚Ğ¸ĞºĞ° + Ğ±Ğ¸Ğ¾Ğ¼Ğ°Ñ€ĞºĞµÑ€Ñ‹)

---

## Value Proposition

### Ğ”Ğ»Ñ Ğ¿Ñ€Ğ¾Ğ´Ğ²Ğ¸Ğ½ÑƒÑ‚Ñ‹Ñ… Ğ±Ğ¸Ğ¾Ñ…Ğ°ĞºĞµÑ€Ğ¾Ğ²

> "Ğ’ÑĞµ Ğ²Ğ°ÑˆĞ¸ Ğ´Ğ°Ğ½Ğ½Ñ‹Ğµ, Ğ¿Ñ€Ğ¾Ñ‚Ğ¾ĞºĞ¾Ğ»Ñ‹ Ğ¸ ÑĞºÑĞ¿ĞµÑ€Ğ¸Ğ¼ĞµĞ½Ñ‚Ñ‹ Ğ² Ğ¾Ğ´Ğ½Ğ¾Ğ¼ Ğ¼ĞµÑÑ‚Ğµ Ñ AI, ĞºĞ¾Ñ‚Ğ¾Ñ€Ñ‹Ğ¹ Ğ¿Ğ¾Ğ½Ğ¸Ğ¼Ğ°ĞµÑ‚ ĞºĞ¾Ğ½Ñ‚ĞµĞºÑÑ‚"

| Ğ¦ĞµĞ½Ğ½Ğ¾ÑÑ‚ÑŒ | ĞšĞ°Ğº Ğ´Ğ¾ÑÑ‚Ğ°Ğ²Ğ»ÑĞµĞ¼ |
|----------|----------------|
| Ğ¦ĞµĞ½Ñ‚Ñ€Ğ°Ğ»Ğ¸Ğ·Ğ°Ñ†Ğ¸Ñ Ğ´Ğ°Ğ½Ğ½Ñ‹Ñ… | 100+ Ğ¸Ğ½Ñ‚ĞµĞ³Ñ€Ğ°Ñ†Ğ¸Ğ¹ Ñ wearables, labs, genomics |
| Custom Ğ¿Ñ€Ğ¾Ñ‚Ğ¾ĞºĞ¾Ğ»Ñ‹ | Ğ—Ğ°Ğ³Ñ€ÑƒĞ·ĞºĞ° PDF/MD â†’ RAG Ğ¸Ğ½Ğ´ĞµĞºÑĞ°Ñ†Ğ¸Ñ â†’ Ğ¿ĞµÑ€ÑĞ¾Ğ½Ğ°Ğ»ÑŒĞ½Ñ‹Ğµ Ñ€ĞµĞºĞ¾Ğ¼ĞµĞ½Ğ´Ğ°Ñ†Ğ¸Ğ¸ |
| N=1 ÑĞºÑĞ¿ĞµÑ€Ğ¸Ğ¼ĞµĞ½Ñ‚Ñ‹ | Biohacker Lab: design â†’ baseline â†’ intervention â†’ analysis |
| ĞŸÑ€Ğ¸Ñ‡Ğ¸Ğ½Ğ½Ğ¾-ÑĞ»ĞµĞ´ÑÑ‚Ğ²ĞµĞ½Ğ½Ñ‹Ğ¹ Ğ°Ğ½Ğ°Ğ»Ğ¸Ğ· | ML-Ğ¼Ğ¾Ğ´ĞµĞ»Ğ¸ Ğ´Ğ»Ñ Ğ²Ñ‹ÑĞ²Ğ»ĞµĞ½Ğ¸Ñ "Ñ‡Ñ‚Ğ¾ Ñ€ĞµĞ°Ğ»ÑŒĞ½Ğ¾ Ñ€Ğ°Ğ±Ğ¾Ñ‚Ğ°ĞµÑ‚" |

### Ğ”Ğ»Ñ health optimizers

> "AI-ĞºĞ¾ÑƒÑ‡, ĞºĞ¾Ñ‚Ğ¾Ñ€Ñ‹Ğ¹ Ğ·Ğ½Ğ°ĞµÑ‚ Ğ²Ğ°Ñ Ğ»ÑƒÑ‡ÑˆĞµ, Ñ‡ĞµĞ¼ Ğ²Ñ‹ ÑĞ°Ğ¼Ğ¸, Ğ¸ Ğ´Ğ°Ñ‘Ñ‚ Ğ¿Ğ¾Ğ½ÑÑ‚Ğ½Ñ‹Ğµ Ñ€ĞµĞºĞ¾Ğ¼ĞµĞ½Ğ´Ğ°Ñ†Ğ¸Ğ¸"

| Ğ¦ĞµĞ½Ğ½Ğ¾ÑÑ‚ÑŒ | ĞšĞ°Ğº Ğ´Ğ¾ÑÑ‚Ğ°Ğ²Ğ»ÑĞµĞ¼ |
|----------|----------------|
| ĞŸĞ¾Ğ½ÑÑ‚Ğ½Ñ‹Ğµ Ñ€ĞµĞºĞ¾Ğ¼ĞµĞ½Ğ´Ğ°Ñ†Ğ¸Ğ¸ | Coach Agent Ğ¿ĞµÑ€ĞµĞ²Ğ¾Ğ´Ğ¸Ñ‚ Ğ´Ğ°Ğ½Ğ½Ñ‹Ğµ Ğ² Ğ´ĞµĞ¹ÑÑ‚Ğ²Ğ¸Ñ |
| Ğ˜Ğ½Ñ‚ĞµĞ³Ñ€Ğ°Ñ†Ğ¸Ñ Ñ ÑƒÑÑ‚Ñ€Ğ¾Ğ¹ÑÑ‚Ğ²Ğ°Ğ¼Ğ¸ | ĞĞ²Ñ‚Ğ¾Ğ¼Ğ°Ñ‚Ğ¸Ñ‡ĞµÑĞºĞ¸Ğ¹ ÑĞ±Ğ¾Ñ€ Ğ´Ğ°Ğ½Ğ½Ñ‹Ñ… Ğ±ĞµĞ· Ñ€ÑƒÑ‡Ğ½Ğ¾Ğ³Ğ¾ Ğ²Ğ²Ğ¾Ğ´Ğ° |
| ĞĞ°ÑƒÑ‡Ğ½Ğ°Ñ Ğ±Ğ°Ğ·Ğ° | Ğ’ÑĞµ Ñ€ĞµĞºĞ¾Ğ¼ĞµĞ½Ğ´Ğ°Ñ†Ğ¸Ğ¸ Ñ ÑÑÑ‹Ğ»ĞºĞ°Ğ¼Ğ¸ Ğ½Ğ° Ğ¸ÑÑĞ»ĞµĞ´Ğ¾Ğ²Ğ°Ğ½Ğ¸Ñ |
| ĞŸÑ€Ğ¾Ğ³Ñ€ĞµÑÑ | Health Score Ğ¸ Weekly Wins Ğ¿Ğ¾ĞºĞ°Ğ·Ñ‹Ğ²Ğ°ÑÑ‚ Ñ€ĞµĞ·ÑƒĞ»ÑŒÑ‚Ğ°Ñ‚ |

### Ğ”Ğ»Ñ longevity-focused

> "Ğ£Ğ¿Ñ€Ğ°Ğ²Ğ»ĞµĞ½Ğ¸Ğµ Ğ±Ğ¸Ğ¾Ğ»Ğ¾Ğ³Ğ¸Ñ‡ĞµÑĞºĞ¸Ğ¼ Ğ²Ğ¾Ğ·Ñ€Ğ°ÑÑ‚Ğ¾Ğ¼ Ñ Ğ½Ğ°ÑƒÑ‡Ğ½Ñ‹Ğ¼ Ğ¿Ğ¾Ğ´Ñ…Ğ¾Ğ´Ğ¾Ğ¼"

| Ğ¦ĞµĞ½Ğ½Ğ¾ÑÑ‚ÑŒ | ĞšĞ°Ğº Ğ´Ğ¾ÑÑ‚Ğ°Ğ²Ğ»ÑĞµĞ¼ |
|----------|----------------|
| Ğ­Ğ¿Ğ¸Ğ³ĞµĞ½ĞµÑ‚Ğ¸Ñ‡ĞµÑĞºĞ¸Ğµ Ñ‡Ğ°ÑÑ‹ | Ğ˜Ğ½Ñ‚ĞµĞ³Ñ€Ğ°Ñ†Ğ¸Ñ Ñ TruDiagnostic, GlycanAge |
| ĞŸÑ€Ğ¾Ñ‚Ğ¾ĞºĞ¾Ğ»Ñ‹ Ğ´Ğ¾Ğ»Ğ³Ğ¾Ğ»ĞµÑ‚Ğ¸Ñ | RAG Ñ Bryan Johnson, Peter Attia, Sinclair |
| Tracking biomarkers | Longevity Agent Ğ°Ğ½Ğ°Ğ»Ğ¸Ğ·Ğ¸Ñ€ÑƒĞµÑ‚ Ñ‚Ñ€ĞµĞ½Ğ´Ñ‹ |
| ĞŸÑ€Ğ¾Ğ³Ğ½Ğ¾Ğ·Ñ‹ | Digital Twin ÑĞ¸Ğ¼ÑƒĞ»Ğ¸Ñ€ÑƒĞµÑ‚ Ñ‚Ñ€Ğ°ĞµĞºÑ‚Ğ¾Ñ€Ğ¸Ñ Ğ·Ğ´Ğ¾Ñ€Ğ¾Ğ²ÑŒÑ |

---

## Target Audience

### Primary Persona: ĞĞ»ĞµĞºÑĞµĞ¹ â€” Advanced Biohacker

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ‘¤ ĞĞ›Ğ•ĞšĞ¡Ğ•Ğ™, 38 Ğ»ĞµÑ‚                                         â”‚
â”‚  IT-Ğ¿Ñ€ĞµĞ´Ğ¿Ñ€Ğ¸Ğ½Ğ¸Ğ¼Ğ°Ñ‚ĞµĞ»ÑŒ, ĞœĞ¾ÑĞºĞ²Ğ°                                 â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  DEMOGRAPHICS                                                â”‚
â”‚  â€¢ Ğ”Ğ¾Ñ…Ğ¾Ğ´: 500K+ â‚½/Ğ¼ĞµÑ                                       â”‚
â”‚  â€¢ ĞĞ±Ñ€Ğ°Ğ·Ğ¾Ğ²Ğ°Ğ½Ğ¸Ğµ: Ğ’Ñ‹ÑÑˆĞµĞµ Ñ‚ĞµÑ…Ğ½Ğ¸Ñ‡ĞµÑĞºĞ¾Ğµ                          â”‚
â”‚  â€¢ Ğ¡ĞµĞ¼ÑŒÑ: Ğ–ĞµĞ½Ğ°Ñ‚, 1 Ñ€ĞµĞ±Ñ‘Ğ½Ğ¾Ğº                                  â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  BIOHACKING STACK                                            â”‚
â”‚  â€¢ Oura Ring (3 Ğ³Ğ¾Ğ´Ğ°)                                       â”‚
â”‚  â€¢ Dexcom G7 (Ğ¿ĞµÑ€Ğ¸Ğ¾Ğ´Ğ¸Ñ‡ĞµÑĞºĞ¸)                                 â”‚
â”‚  â€¢ 23andMe + TruDiagnostic                                  â”‚
â”‚  â€¢ NMN/Resveratrol/Metformin Ğ¿Ñ€Ğ¾Ñ‚Ğ¾ĞºĞ¾Ğ»                       â”‚
â”‚  â€¢ ĞĞ½Ğ°Ğ»Ğ¸Ğ·Ñ‹ Ğ² INVITRO ĞºĞ°Ğ¶Ğ´Ñ‹Ğµ 3 Ğ¼ĞµÑÑÑ†Ğ°                        â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  GOALS                                                       â”‚
â”‚  âœ“ Ğ¡Ğ½Ğ¸Ğ·Ğ¸Ñ‚ÑŒ Ğ±Ğ¸Ğ¾Ğ»Ğ¾Ğ³Ğ¸Ñ‡ĞµÑĞºĞ¸Ğ¹ Ğ²Ğ¾Ğ·Ñ€Ğ°ÑÑ‚ Ğ½Ğ° 5 Ğ»ĞµÑ‚                   â”‚
â”‚  âœ“ ĞĞ¿Ñ‚Ğ¸Ğ¼Ğ¸Ğ·Ğ¸Ñ€Ğ¾Ğ²Ğ°Ñ‚ÑŒ ĞºĞ¾Ğ³Ğ½Ğ¸Ñ‚Ğ¸Ğ²Ğ½ÑƒÑ Ğ¿Ñ€Ğ¾Ğ¸Ğ·Ğ²Ğ¾Ğ´Ğ¸Ñ‚ĞµĞ»ÑŒĞ½Ğ¾ÑÑ‚ÑŒ            â”‚
â”‚  âœ“ ĞŸĞ¾Ğ½ÑÑ‚ÑŒ, ĞºĞ°ĞºĞ¸Ğµ Ğ¸Ğ½Ñ‚ĞµÑ€Ğ²ĞµĞ½Ñ†Ğ¸Ğ¸ Ñ€ĞµĞ°Ğ»ÑŒĞ½Ğ¾ Ñ€Ğ°Ğ±Ğ¾Ñ‚Ğ°ÑÑ‚               â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  PAIN POINTS                                                 â”‚
â”‚  âœ— Ğ”Ğ°Ğ½Ğ½Ñ‹Ğµ Ñ€Ğ°Ğ·Ğ±Ñ€Ğ¾ÑĞ°Ğ½Ñ‹ Ğ¿Ğ¾ 7+ Ğ¿Ñ€Ğ¸Ğ»Ğ¾Ğ¶ĞµĞ½Ğ¸ÑĞ¼                      â”‚
â”‚  âœ— ĞĞµĞ²Ğ¾Ğ·Ğ¼Ğ¾Ğ¶Ğ½Ğ¾ Ğ¿Ğ¾Ğ½ÑÑ‚ÑŒ cause-effect                           â”‚
â”‚  âœ— ĞĞµÑ‚ Ğ¿ĞµÑ€ÑĞ¾Ğ½Ğ°Ğ»Ğ¸Ğ·Ğ°Ñ†Ğ¸Ğ¸ Ğ¿Ğ¾Ğ´ Ğ¼Ğ¾Ñ Ğ³ĞµĞ½ĞµÑ‚Ğ¸ĞºÑƒ                      â”‚
â”‚  âœ— Ğ¢Ñ€Ğ°Ñ‡Ñƒ 5+ Ñ‡Ğ°ÑĞ¾Ğ²/Ğ½ĞµĞ´ĞµĞ»Ñ Ğ½Ğ° Ñ€ÑƒÑ‡Ğ½ÑƒÑ Ğ°Ğ½Ğ°Ğ»Ğ¸Ñ‚Ğ¸ĞºÑƒ               â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  WILLINGNESS TO PAY                                          â”‚
â”‚  â€¢ 5,000-15,000 â‚½/Ğ¼ĞµÑ Ğ·Ğ° Ñ€ĞµĞ°Ğ»ÑŒĞ½ÑƒÑ Ñ†ĞµĞ½Ğ½Ğ¾ÑÑ‚ÑŒ                  â”‚
â”‚  â€¢ Ğ£Ğ¶Ğµ Ñ‚Ñ€Ğ°Ñ‚Ğ¸Ñ‚ 30K+/Ğ¼ĞµÑ Ğ½Ğ° Ğ´Ğ¾Ğ±Ğ°Ğ²ĞºĞ¸ Ğ¸ Ñ‚ĞµÑÑ‚Ñ‹                   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Secondary Persona: ĞœĞ°Ñ€Ğ¸Ñ â€” Health Optimizer

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ‘¤ ĞœĞĞ Ğ˜Ğ¯, 32 Ğ³Ğ¾Ğ´Ğ°                                          â”‚
â”‚  ĞœĞ°Ñ€ĞºĞµÑ‚Ğ¸Ğ½Ğ³-Ğ´Ğ¸Ñ€ĞµĞºÑ‚Ğ¾Ñ€, Ğ¡Ğ°Ğ½ĞºÑ‚-ĞŸĞµÑ‚ĞµÑ€Ğ±ÑƒÑ€Ğ³                        â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  DEMOGRAPHICS                                                â”‚
â”‚  â€¢ Ğ”Ğ¾Ñ…Ğ¾Ğ´: 200-300K â‚½/Ğ¼ĞµÑ                                    â”‚
â”‚  â€¢ ĞĞ±Ñ€Ğ°Ğ·Ğ¾Ğ²Ğ°Ğ½Ğ¸Ğµ: Ğ’Ñ‹ÑÑˆĞµĞµ ÑĞºĞ¾Ğ½Ğ¾Ğ¼Ğ¸Ñ‡ĞµÑĞºĞ¾Ğµ                        â”‚
â”‚  â€¢ Ğ¡ĞµĞ¼ÑŒÑ: ĞĞµ Ğ·Ğ°Ğ¼ÑƒĞ¶ĞµĞ¼                                        â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  HEALTH STACK                                                â”‚
â”‚  â€¢ Apple Watch (2 Ğ³Ğ¾Ğ´Ğ°)                                     â”‚
â”‚  â€¢ MyFitnessPal (Ğ¿ĞµÑ€Ğ¸Ğ¾Ğ´Ğ¸Ñ‡ĞµÑĞºĞ¸)                              â”‚
â”‚  â€¢ Headspace (Ğ¿Ğ¾Ğ´Ğ¿Ğ¸ÑĞºĞ°)                                     â”‚
â”‚  â€¢ ĞĞ½Ğ°Ğ»Ğ¸Ğ·Ñ‹ 1-2 Ñ€Ğ°Ğ·Ğ° Ğ² Ğ³Ğ¾Ğ´                                   â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  GOALS                                                       â”‚
â”‚  âœ“ Ğ‘Ğ¾Ğ»ÑŒÑˆĞµ ÑĞ½ĞµÑ€Ğ³Ğ¸Ğ¸ Ğ¸ Ñ„Ğ¾ĞºÑƒÑĞ° Ğ´Ğ»Ñ Ñ€Ğ°Ğ±Ğ¾Ñ‚Ñ‹                       â”‚
â”‚  âœ“ Ğ£Ğ»ÑƒÑ‡ÑˆĞ¸Ñ‚ÑŒ ĞºĞ°Ñ‡ĞµÑÑ‚Ğ²Ğ¾ ÑĞ½Ğ°                                    â”‚
â”‚  âœ“ ĞŸĞ¾Ğ½ÑÑ‚Ğ½Ñ‹Ğµ Ñ€ĞµĞºĞ¾Ğ¼ĞµĞ½Ğ´Ğ°Ñ†Ğ¸Ğ¸ Ğ±ĞµĞ· PhD Ğ² Ğ±Ğ¸Ğ¾Ñ…Ğ°ĞºĞ¸Ğ½Ğ³Ğµ               â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  PAIN POINTS                                                 â”‚
â”‚  âœ— Ğ˜Ğ½Ñ„Ğ¾Ñ€Ğ¼Ğ°Ñ†Ğ¸Ğ¾Ğ½Ğ½Ñ‹Ğ¹ Ğ¿ĞµÑ€ĞµĞ³Ñ€ÑƒĞ·                                  â”‚
â”‚  âœ— ĞĞµ Ğ·Ğ½Ğ°ĞµÑ‚, Ñ Ñ‡ĞµĞ³Ğ¾ Ğ½Ğ°Ñ‡Ğ°Ñ‚ÑŒ                                  â”‚
â”‚  âœ— Ğ¡Ğ»Ğ¾Ğ¶Ğ½Ğ¾ Ğ¸Ğ½Ñ‚ĞµÑ€Ğ¿Ñ€ĞµÑ‚Ğ¸Ñ€Ğ¾Ğ²Ğ°Ñ‚ÑŒ Ğ´Ğ°Ğ½Ğ½Ñ‹Ğµ Ñ Ñ‡Ğ°ÑĞ¾Ğ²                   â”‚
â”‚  âœ— Ğ¡Ğ¾Ğ²ĞµÑ‚Ñ‹ Ğ² Ğ¸Ğ½Ñ‚ĞµÑ€Ğ½ĞµÑ‚Ğµ Ğ¿Ñ€Ğ¾Ñ‚Ğ¸Ğ²Ğ¾Ñ€ĞµÑ‡Ğ°Ñ‚ Ğ´Ñ€ÑƒĞ³ Ğ´Ñ€ÑƒĞ³Ñƒ              â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  WILLINGNESS TO PAY                                          â”‚
â”‚  â€¢ 1,000-2,500 â‚½/Ğ¼ĞµÑ                                        â”‚
â”‚  â€¢ Ğ“Ğ¾Ñ‚Ğ¾Ğ²Ğ° Ğ¿Ğ»Ğ°Ñ‚Ğ¸Ñ‚ÑŒ Ğ·Ğ° ÑƒĞ´Ğ¾Ğ±ÑÑ‚Ğ²Ğ¾ Ğ¸ Ñ€ĞµĞ·ÑƒĞ»ÑŒÑ‚Ğ°Ñ‚                   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Tertiary Persona: Ğ˜Ğ³Ğ¾Ñ€ÑŒ â€” Longevity Enthusiast

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ‘¤ Ğ˜Ğ“ĞĞ Ğ¬, 52 Ğ³Ğ¾Ğ´Ğ°                                          â”‚
â”‚  Ğ˜Ğ½Ğ²ĞµÑÑ‚Ğ¾Ñ€, ĞœĞ¾ÑĞºĞ²Ğ°                                           â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  FOCUS                                                       â”‚
â”‚  â€¢ Ğ‘Ğ¸Ğ¾Ğ»Ğ¾Ğ³Ğ¸Ñ‡ĞµÑĞºĞ¸Ğ¹ Ğ²Ğ¾Ğ·Ñ€Ğ°ÑÑ‚ Ğ¸ ÑĞ¿Ğ¸Ğ³ĞµĞ½ĞµÑ‚Ğ¸ĞºĞ°                      â”‚
â”‚  â€¢ Ğ“Ğ¾Ñ€Ğ¼Ğ¾Ğ½Ğ°Ğ»ÑŒĞ½Ğ°Ñ Ğ¾Ğ¿Ñ‚Ğ¸Ğ¼Ğ¸Ğ·Ğ°Ñ†Ğ¸Ñ                                 â”‚
â”‚  â€¢ ĞšĞ°Ñ€Ğ´Ğ¸Ğ¾-Ğ·Ğ´Ğ¾Ñ€Ğ¾Ğ²ÑŒĞµ Ğ¸ Ğ¿Ñ€Ğ¾Ñ„Ğ¸Ğ»Ğ°ĞºÑ‚Ğ¸ĞºĞ°                           â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  GOALS                                                       â”‚
â”‚  âœ“ ĞŸÑ€Ğ¾Ğ¶Ğ¸Ñ‚ÑŒ 120+ Ğ»ĞµÑ‚ Ğ² Ğ·Ğ´Ğ¾Ñ€Ğ¾Ğ²Ğ¾Ğ¼ Ñ‚ĞµĞ»Ğµ                         â”‚
â”‚  âœ“ ĞÑ‚ÑĞ»ĞµĞ¶Ğ¸Ğ²Ğ°Ñ‚ÑŒ pace of aging                                â”‚
â”‚  âœ“ ĞĞ¿Ñ‚Ğ¸Ğ¼Ğ¸Ğ·Ğ¸Ñ€Ğ¾Ğ²Ğ°Ñ‚ÑŒ Ğ¿Ğ¾Ğ´ Ğ½Ğ°ÑƒÑ‡Ğ½Ñ‹Ğµ Ğ¿Ñ€Ğ¾Ñ‚Ğ¾ĞºĞ¾Ğ»Ñ‹                     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  WILLINGNESS TO PAY                                          â”‚
â”‚  â€¢ 10,000-50,000 â‚½/Ğ¼ĞµÑ Ğ·Ğ° premium ÑĞµÑ€Ğ²Ğ¸Ñ                    â”‚
â”‚  â€¢ Ğ¦ĞµĞ½Ğ¸Ñ‚ ĞºĞ¾Ğ½ÑÑŒĞµÑ€Ğ¶-Ğ¿Ğ¾Ğ´Ñ…Ğ¾Ğ´ Ğ¸ ÑĞºÑĞ¿ĞµÑ€Ñ‚Ğ½Ñ‹Ğµ ĞºĞ¾Ğ½ÑÑƒĞ»ÑŒÑ‚Ğ°Ñ†Ğ¸Ğ¸          â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## Success Metrics

### North Star Metric

> **Monthly Active Users using AI agents for health decisions**

ĞŸĞ¾Ğ»ÑŒĞ·Ğ¾Ğ²Ğ°Ñ‚ĞµĞ»ÑŒ ÑÑ‡Ğ¸Ñ‚Ğ°ĞµÑ‚ÑÑ "Ğ°ĞºÑ‚Ğ¸Ğ²Ğ½Ñ‹Ğ¼", ĞµÑĞ»Ğ¸ Ğ·Ğ° Ğ¼ĞµÑÑÑ†:
- ĞŸĞ¾Ğ»ÑƒÑ‡Ğ¸Ğ» â‰¥5 AI-Ñ€ĞµĞºĞ¾Ğ¼ĞµĞ½Ğ´Ğ°Ñ†Ğ¸Ğ¹
- ĞÑ‚Ğ¼ĞµÑ‚Ğ¸Ğ» Ğ²Ñ‹Ğ¿Ğ¾Ğ»Ğ½ĞµĞ½Ğ¸Ğµ â‰¥3 Ñ€ĞµĞºĞ¾Ğ¼ĞµĞ½Ğ´Ğ°Ñ†Ğ¸Ğ¹
- Ğ¡Ğ¸Ğ½Ñ…Ñ€Ğ¾Ğ½Ğ¸Ğ·Ğ¸Ñ€Ğ¾Ğ²Ğ°Ğ» Ğ´Ğ°Ğ½Ğ½Ñ‹Ğµ Ñ…Ğ¾Ñ‚Ñ Ğ±Ñ‹ Ñ 1 Ğ¸ÑÑ‚Ğ¾Ñ‡Ğ½Ğ¸ĞºĞ°

### AARRR Metrics

| Stage | Metric | Target (M6) | Target (M12) |
|-------|--------|-------------|--------------|
| **Acquisition** | Signups | 10,000 | 50,000 |
| **Activation** | Users who connected â‰¥2 data sources + got first insight | 40% | 50% |
| **Retention** | M1 Retention | 50% | 60% |
| **Revenue** | Free â†’ Paid conversion | 5% | 8% |
| **Referral** | Viral coefficient | 0.3 | 0.5 |

### Product Metrics

| Metric | Definition | Target |
|--------|------------|--------|
| **AI Query Volume** | Queries per user per week | â‰¥5 |
| **Data Sources Connected** | Avg sources per active user | â‰¥3 |
| **Health Score Improvement** | % users with improved score (M3) | â‰¥60% |
| **Experiment Completion** | % started N=1 experiments completed | â‰¥40% |
| **Protocol Adherence** | % recommended actions completed | â‰¥70% |
| **NPS** | Net Promoter Score | â‰¥50 |

### Health Outcome Metrics (Long-term)

| Metric | Measurement | Target |
|--------|-------------|--------|
| Biological age reduction | TruDiagnostic delta | -1 year avg |
| HRV improvement | RMSSD baseline â†’ M6 | +15% avg |
| Sleep quality | Deep sleep % | +10% avg |
| User-reported energy | Survey 1-10 | +2 points avg |

---

## High-Level Solution

### ĞÑ€Ñ…Ğ¸Ñ‚ĞµĞºÑ‚ÑƒÑ€Ğ° Ğ¿Ñ€Ğ¾Ğ´ÑƒĞºÑ‚Ğ°

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                        BIOMAX AI v2.0                            â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                  â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚                    USER INTERFACES                         â”‚  â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”      â”‚  â”‚
â”‚  â”‚  â”‚Telegram â”‚  â”‚ Mobile  â”‚  â”‚   Web   â”‚  â”‚  Voice  â”‚      â”‚  â”‚
â”‚  â”‚  â”‚   Bot   â”‚  â”‚   App   â”‚  â”‚Dashboardâ”‚  â”‚ (ĞĞ»Ğ¸ÑĞ°) â”‚      â”‚  â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜      â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                              â”‚                                   â”‚
â”‚                              â–¼                                   â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚                 15 AI AGENTS + ORCHESTRATOR                â”‚  â”‚
â”‚  â”‚                                                            â”‚  â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”         â”‚  â”‚
â”‚  â”‚  â”‚Nutritionâ”‚ â”‚  Sleep  â”‚ â”‚Cognitiveâ”‚ â”‚ Fitness â”‚         â”‚  â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜         â”‚  â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”         â”‚  â”‚
â”‚  â”‚  â”‚Longevityâ”‚ â”‚ Mental  â”‚ â”‚Lab Interpâ”‚ â”‚Genomicsâ”‚         â”‚  â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜         â”‚  â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”         â”‚  â”‚
â”‚  â”‚  â”‚  Coach  â”‚ â”‚Research â”‚ â”‚ Safety  â”‚ â”‚ Custom  â”‚         â”‚  â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜         â”‚  â”‚
â”‚  â”‚                    + Integration Agent                     â”‚  â”‚
â”‚  â”‚                    + Orchestrator Agent                    â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                              â”‚                                   â”‚
â”‚                              â–¼                                   â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚                    CORE MODULES                            â”‚  â”‚
â”‚  â”‚                                                            â”‚  â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”                   â”‚  â”‚
â”‚  â”‚  â”‚  Health Score  â”‚  â”‚  Digital Twin  â”‚                   â”‚  â”‚
â”‚  â”‚  â”‚ (8 dimensions) â”‚  â”‚  (Simulations) â”‚                   â”‚  â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜                   â”‚  â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”                   â”‚  â”‚
â”‚  â”‚  â”‚ Biohacker Lab  â”‚  â”‚ Safety Module  â”‚                   â”‚  â”‚
â”‚  â”‚  â”‚(N=1 experiments)â”‚ â”‚(Contraindications)â”‚                â”‚  â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜                   â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                              â”‚                                   â”‚
â”‚                              â–¼                                   â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚                    DATA LAYER                              â”‚  â”‚
â”‚  â”‚                                                            â”‚  â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚  â”‚
â”‚  â”‚  â”‚              100+ INTEGRATIONS                      â”‚   â”‚  â”‚
â”‚  â”‚  â”‚  Wearables â”‚ CGM â”‚ Labs â”‚ Genomics â”‚ Microbiome    â”‚   â”‚  â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚  â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚  â”‚
â”‚  â”‚  â”‚              CUSTOM RAG (User KB)                   â”‚   â”‚  â”‚
â”‚  â”‚  â”‚  Protocols â”‚ Research â”‚ Personal Experiments        â”‚   â”‚  â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### ĞšĞ»ÑÑ‡ĞµĞ²Ñ‹Ğµ Ğ¼Ğ¾Ğ´ÑƒĞ»Ğ¸

| ĞœĞ¾Ğ´ÑƒĞ»ÑŒ | ĞĞ¿Ğ¸ÑĞ°Ğ½Ğ¸Ğµ | Ğ£Ğ½Ğ¸ĞºĞ°Ğ»ÑŒĞ½Ğ¾ÑÑ‚ÑŒ |
|--------|----------|--------------|
| **ĞœÑƒĞ»ÑŒÑ‚Ğ¸Ğ°Ğ³ĞµĞ½Ñ‚Ğ½Ğ°Ñ AI-ÑĞ¸ÑÑ‚ĞµĞ¼Ğ°** | 15 ÑĞ¿ĞµÑ†Ğ¸Ğ°Ğ»Ğ¸Ğ·Ğ¸Ñ€Ğ¾Ğ²Ğ°Ğ½Ğ½Ñ‹Ñ… Ğ°Ğ³ĞµĞ½Ñ‚Ğ¾Ğ² Ñ Ğ´Ğ¸Ğ½Ğ°Ğ¼Ğ¸Ñ‡ĞµÑĞºĞ¾Ğ¹ Ğ¾Ñ€ĞºĞµÑÑ‚Ñ€Ğ°Ñ†Ğ¸ĞµĞ¹ | ĞĞµÑ‚ Ğ°Ğ½Ğ°Ğ»Ğ¾Ğ³Ğ¾Ğ² Ğ½Ğ° Ñ€Ñ‹Ğ½ĞºĞµ |
| **Health Score** | ĞšĞ¾Ğ¼Ğ¿Ğ»ĞµĞºÑĞ½Ğ°Ñ Ğ¾Ñ†ĞµĞ½ĞºĞ° Ğ¿Ğ¾ 8 Ğ¸Ğ·Ğ¼ĞµÑ€ĞµĞ½Ğ¸ÑĞ¼ wellness (0-100) | ĞŸĞµÑ€ÑĞ¾Ğ½Ğ°Ğ»Ğ¸Ğ·Ğ¸Ñ€ÑƒĞµĞ¼Ñ‹Ğµ Ğ²ĞµÑĞ° Ğ¿Ğ¾Ğ´ Ñ†ĞµĞ»Ğ¸ |
| **Custom RAG** | ĞŸĞ¾Ğ»ÑŒĞ·Ğ¾Ğ²Ğ°Ñ‚ĞµĞ»ÑŒÑĞºĞ°Ñ Ğ±Ğ°Ğ·Ğ° Ğ·Ğ½Ğ°Ğ½Ğ¸Ğ¹ Ñ Ğ¿Ñ€Ğ¾Ñ‚Ğ¾ĞºĞ¾Ğ»Ğ°Ğ¼Ğ¸ Ğ¸ Ğ¸ÑÑĞ»ĞµĞ´Ğ¾Ğ²Ğ°Ğ½Ğ¸ÑĞ¼Ğ¸ | ĞšĞ°Ğ¶Ğ´Ñ‹Ğ¹ Ğ¿Ğ¾Ğ»ÑŒĞ·Ğ¾Ğ²Ğ°Ñ‚ĞµĞ»ÑŒ ÑÑ‚Ñ€Ğ¾Ğ¸Ñ‚ ÑĞ²Ğ¾Ñ KB |
| **Biohacker Lab** | ĞœĞ¾Ğ´ÑƒĞ»ÑŒ Ğ´Ğ»Ñ N=1 ÑĞºÑĞ¿ĞµÑ€Ğ¸Ğ¼ĞµĞ½Ñ‚Ğ¾Ğ² Ñ Ğ½Ğ°ÑƒÑ‡Ğ½Ñ‹Ğ¼ Ğ¿Ğ¾Ğ´Ñ…Ğ¾Ğ´Ğ¾Ğ¼ | ML-Ğ°Ğ½Ğ°Ğ»Ğ¸Ğ· Ğ¿Ñ€Ğ¸Ñ‡Ğ¸Ğ½Ğ½Ğ¾-ÑĞ»ĞµĞ´ÑÑ‚Ğ²ĞµĞ½Ğ½Ñ‹Ñ… ÑĞ²ÑĞ·ĞµĞ¹ |
| **Digital Twin** | Ğ’Ğ¸Ñ€Ñ‚ÑƒĞ°Ğ»ÑŒĞ½Ğ°Ñ Ğ¼Ğ¾Ğ´ĞµĞ»ÑŒ Ğ¾Ñ€Ğ³Ğ°Ğ½Ğ¸Ğ·Ğ¼Ğ° Ğ´Ğ»Ñ ÑĞ¸Ğ¼ÑƒĞ»ÑÑ†Ğ¸Ğ¹ | ĞŸÑ€Ğ¾Ğ³Ğ½Ğ¾Ğ·Ñ‹ "Ñ‡Ñ‚Ğ¾ Ğ±ÑƒĞ´ĞµÑ‚ Ñ‡ĞµÑ€ĞµĞ· 5 Ğ»ĞµÑ‚" |
| **Safety Module** | ĞœĞµĞ´Ğ¸Ñ†Ğ¸Ğ½ÑĞºĞ¸Ğµ Ğ³Ñ€Ğ°Ğ½Ğ¸Ñ†Ñ‹, ĞºĞ¾Ğ½Ñ‚Ñ€Ğ¿Ğ¾ĞºĞ°Ğ·Ğ°Ğ½Ğ¸Ñ, red flags | ĞĞ±ÑĞ·Ğ°Ñ‚ĞµĞ»ĞµĞ½ Ğ´Ğ»Ñ Ñ€ĞµĞ°Ğ»ÑŒĞ½Ğ¾Ğ³Ğ¾ Ğ¿Ñ€Ğ¾Ğ´ÑƒĞºÑ‚Ğ° |

---

## Competitive Advantage

### ĞŸĞ¾Ğ·Ğ¸Ñ†Ğ¸Ğ¾Ğ½Ğ¸Ñ€Ğ¾Ğ²Ğ°Ğ½Ğ¸Ğµ

```
                    Ğ¡ĞŸĞ•Ğ¦Ğ˜ĞĞ›Ğ˜Ğ—ĞĞ¦Ğ˜Ğ¯ (ÑƒĞ·ĞºĞ¾)
                           â”‚
         InsideTracker     â”‚     
         (labs only)       â”‚     Levels (glucose only)
                           â”‚     
    â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
    Ğ”ĞĞĞĞ«Ğ•                 â”‚                    AI
    (Ğ¿Ğ¾ĞºĞ°Ğ·Ñ‹Ğ²Ğ°ĞµĞ¼)           â”‚            (Ñ€ĞµĞºĞ¾Ğ¼ĞµĞ½Ğ´ÑƒĞµĞ¼)
                           â”‚     
         Oura/WHOOP        â”‚     BIOMAX AI â˜…
         (wearables only)  â”‚     (all categories + AI + custom KB)
                           â”‚     
                           â”‚
                    ĞĞ¥Ğ’ĞĞ¢ (ÑˆĞ¸Ñ€Ğ¾ĞºĞ¾)
```

### ĞšĞ¾Ğ½ĞºÑƒÑ€ĞµĞ½Ñ‚Ğ½Ñ‹Ğµ Ğ¿Ñ€ĞµĞ¸Ğ¼ÑƒÑ‰ĞµÑÑ‚Ğ²Ğ°

| # | ĞŸÑ€ĞµĞ¸Ğ¼ÑƒÑ‰ĞµÑÑ‚Ğ²Ğ¾ | ĞĞ¿Ğ¸ÑĞ°Ğ½Ğ¸Ğµ | ĞŸĞ¾Ñ‡ĞµĞ¼Ñƒ Ñ‚Ñ€ÑƒĞ´Ğ½Ğ¾ ÑĞºĞ¾Ğ¿Ğ¸Ñ€Ğ¾Ğ²Ğ°Ñ‚ÑŒ |
|---|--------------|----------|---------------------------|
| 1 | **ĞŸĞ¾Ğ»Ğ½Ğ¾Ñ‚Ğ° Ğ¾Ñ…Ğ²Ğ°Ñ‚Ğ°** | 12 Ğ¼ĞµĞ³Ğ°-ĞºĞ°Ñ‚ĞµĞ³Ğ¾Ñ€Ğ¸Ğ¹, 60+ ÑÑƒĞ±ĞºĞ°Ñ‚ĞµĞ³Ğ¾Ñ€Ğ¸Ğ¹, 200+ Ğ¼ĞµÑ‚Ğ¾Ğ´Ğ¸Ğº | Ğ¢Ñ€ĞµĞ±ÑƒĞµÑ‚ Ğ³Ğ»ÑƒĞ±Ğ¾ĞºĞ¾Ğ¹ ÑĞºÑĞ¿ĞµÑ€Ñ‚Ğ¸Ğ·Ñ‹ Ğ² ĞºĞ°Ğ¶Ğ´Ğ¾Ğ¹ Ğ¾Ğ±Ğ»Ğ°ÑÑ‚Ğ¸ |
| 2 | **AI-first Ğ°Ñ€Ñ…Ğ¸Ñ‚ĞµĞºÑ‚ÑƒÑ€Ğ°** | 15 ÑĞ¿ĞµÑ†Ğ¸Ğ°Ğ»Ğ¸Ğ·Ğ¸Ñ€Ğ¾Ğ²Ğ°Ğ½Ğ½Ñ‹Ñ… Ğ°Ğ³ĞµĞ½Ñ‚Ğ¾Ğ² vs. rule-based ÑĞ¸ÑÑ‚ĞµĞ¼Ñ‹ | Ğ¡Ğ»Ğ¾Ğ¶Ğ½Ğ¾ÑÑ‚ÑŒ Ğ¾Ñ€ĞºĞµÑÑ‚Ñ€Ğ°Ñ†Ğ¸Ğ¸ Ğ¸ Ğ¾Ğ±ÑƒÑ‡ĞµĞ½Ğ¸Ñ |
| 3 | **Custom RAG** | ĞŸĞ¾Ğ»ÑŒĞ·Ğ¾Ğ²Ğ°Ñ‚ĞµĞ»Ğ¸ ÑĞ¾Ğ·Ğ´Ğ°ÑÑ‚ Ğ¿ĞµÑ€ÑĞ¾Ğ½Ğ°Ğ»ÑŒĞ½ÑƒÑ KB | Network effects: Ñ‡ĞµĞ¼ Ğ±Ğ¾Ğ»ÑŒÑˆĞµ Ğ´Ğ°Ğ½Ğ½Ñ‹Ñ…, Ñ‚ĞµĞ¼ Ğ»ÑƒÑ‡ÑˆĞµ Ñ€ĞµĞºĞ¾Ğ¼ĞµĞ½Ğ´Ğ°Ñ†Ğ¸Ğ¸ |
| 4 | **N=1 ÑĞºÑĞ¿ĞµÑ€Ğ¸Ğ¼ĞµĞ½Ñ‚Ñ‹** | ĞĞ°ÑƒÑ‡Ğ½Ñ‹Ğ¹ Ğ¿Ğ¾Ğ´Ñ…Ğ¾Ğ´ Ğº Ğ¿ĞµÑ€ÑĞ¾Ğ½Ğ°Ğ»ÑŒĞ½Ğ¾Ğ¼Ñƒ Ğ±Ğ¸Ğ¾Ñ…Ğ°ĞºĞ¸Ğ½Ğ³Ñƒ | Ğ¢Ñ€ĞµĞ±ÑƒĞµÑ‚ ML-ÑĞºÑĞ¿ĞµÑ€Ñ‚Ğ¸Ğ·Ñ‹ + UX Ğ´Ğ»Ñ ÑĞ»Ğ¾Ğ¶Ğ½Ñ‹Ñ… ĞºĞ¾Ğ½Ñ†ĞµĞ¿Ñ†Ğ¸Ğ¹ |
| 5 | **Ğ Ğ¾ÑÑĞ¸Ğ¹ÑĞºĞ°Ñ Ğ»Ğ¾ĞºĞ°Ğ»Ğ¸Ğ·Ğ°Ñ†Ğ¸Ñ** | 152-Ğ¤Ğ—, Ğ»Ğ¾ĞºĞ°Ğ»ÑŒĞ½Ñ‹Ğµ Ğ»Ğ°Ğ±Ğ¾Ñ€Ğ°Ñ‚Ğ¾Ñ€Ğ¸Ğ¸, GigaChat | BigTech Ğ½Ğµ Ğ¿Ñ€Ğ¸Ğ¾Ñ€Ğ¸Ñ‚Ğ¸Ğ·Ğ¸Ñ€ÑƒĞµÑ‚ RU Ñ€Ñ‹Ğ½Ğ¾Ğº |

### Ğ—Ğ°Ñ‰Ğ¸Ñ‚Ğ° Ğ¾Ñ‚ BigTech (Apple, Google)

| Ğ£Ğ³Ñ€Ğ¾Ğ·Ğ° | ĞĞ°ÑˆĞ° ÑÑ‚Ñ€Ğ°Ñ‚ĞµĞ³Ğ¸Ñ |
|--------|----------------|
| Apple Health Ğ¸Ğ½Ñ‚ĞµĞ³Ñ€Ğ¸Ñ€ÑƒĞµÑ‚ AI | Ğ¤Ğ¾ĞºÑƒÑ Ğ½Ğ° Ğ¿Ñ€Ğ¾Ğ´Ğ²Ğ¸Ğ½ÑƒÑ‚Ñ‹Ñ… Ğ±Ğ¸Ğ¾Ñ…Ğ°ĞºĞµÑ€Ğ¾Ğ² (Ğ½Ğµ mass market) |
| Google Ğ·Ğ°Ğ¿ÑƒÑĞºĞ°ĞµÑ‚ health assistant | Ğ“Ğ»ÑƒĞ±Ğ¾ĞºĞ°Ñ Ğ¿ĞµÑ€ÑĞ¾Ğ½Ğ°Ğ»Ğ¸Ğ·Ğ°Ñ†Ğ¸Ñ Ñ‡ĞµÑ€ĞµĞ· Custom RAG |
| Wearable-Ğ¿Ñ€Ğ¾Ğ¸Ğ·Ğ²Ğ¾Ğ´Ğ¸Ñ‚ĞµĞ»Ğ¸ Ğ´Ğ¾Ğ±Ğ°Ğ²Ğ»ÑÑÑ‚ AI | ĞĞ³Ñ€ĞµĞ³Ğ°Ñ†Ğ¸Ñ Ğ´Ğ°Ğ½Ğ½Ñ‹Ñ… ÑĞ¾ Ğ’Ğ¡Ğ•Ğ¥ ÑƒÑÑ‚Ñ€Ğ¾Ğ¹ÑÑ‚Ğ² |

---

## Key Assumptions

### Validated Assumptions âœ…

| Assumption | Evidence |
|------------|----------|
| Ğ‘Ğ¸Ğ¾Ñ…Ğ°ĞºĞµÑ€Ñ‹ Ñ‚Ñ€Ğ°Ñ‚ÑÑ‚ 5+ Ñ‡Ğ°ÑĞ¾Ğ² Ğ½Ğ° Ñ€ÑƒÑ‡Ğ½ÑƒÑ Ğ°Ğ½Ğ°Ğ»Ğ¸Ñ‚Ğ¸ĞºÑƒ | User research (n=15 Ğ¸Ğ½Ñ‚ĞµÑ€Ğ²ÑŒÑ) |
| Ğ“Ğ¾Ñ‚Ğ¾Ğ²Ğ½Ğ¾ÑÑ‚ÑŒ Ğ¿Ğ»Ğ°Ñ‚Ğ¸Ñ‚ÑŒ 2,000-10,000 â‚½/Ğ¼ĞµÑ | Competitive analysis pricing |
| 152-Ğ¤Ğ— Ğ½Ğµ Ğ±Ğ»Ğ¾ĞºĞ¸Ñ€ÑƒĞµÑ‚ wellness-Ğ¿Ñ€Ğ¾Ğ´ÑƒĞºÑ‚Ñ‹ | Ğ®Ñ€Ğ¸Ğ´Ğ¸Ñ‡ĞµÑĞºĞ°Ñ ÑĞºÑĞ¿ĞµÑ€Ñ‚Ğ¸Ğ·Ğ° |

### Assumptions to Validate ğŸ”„

| Assumption | How to Validate | Risk if Wrong |
|------------|-----------------|---------------|
| Telegram Bot Ğ´Ğ¾ÑÑ‚Ğ°Ñ‚Ğ¾Ñ‡ĞµĞ½ ĞºĞ°Ğº MVP interface | Beta test M1 | Pivot to mobile-first |
| Custom RAG Ğ´Ğ°Ñ‘Ñ‚ Ğ·Ğ½Ğ°Ñ‡Ğ¸Ğ¼Ğ¾Ğµ ÑƒĞ»ÑƒÑ‡ÑˆĞµĞ½Ğ¸Ğµ Ñ€ĞµĞºĞ¾Ğ¼ĞµĞ½Ğ´Ğ°Ñ†Ğ¸Ğ¹ | A/B test M2-M3 | Deprioritize feature |
| ĞŸĞ¾Ğ»ÑŒĞ·Ğ¾Ğ²Ğ°Ñ‚ĞµĞ»Ğ¸ Ğ±ÑƒĞ´ÑƒÑ‚ Ğ·Ğ°Ğ³Ñ€ÑƒĞ¶Ğ°Ñ‚ÑŒ ÑĞ²Ğ¾Ğ¸ Ğ¿Ñ€Ğ¾Ñ‚Ğ¾ĞºĞ¾Ğ»Ñ‹ | Usage analytics M1-M3 | Simplify KB approach |
| GigaChat Ğ´Ğ¾ÑÑ‚Ğ°Ñ‚Ğ¾Ñ‡ĞµĞ½ Ğ´Ğ»Ñ Ğ¼ĞµĞ´Ğ¸Ñ†Ğ¸Ğ½ÑĞºĞ¾Ğ³Ğ¾ ĞºĞ¾Ğ½Ñ‚ĞµĞºÑÑ‚Ğ° | Quality evaluation M1 | Add GPT-4o fallback |

---

## Key Risks

| Risk | Probability | Impact | Mitigation |
|------|-------------|--------|------------|
| **Ğ ĞµĞ³ÑƒĞ»ÑÑ‚Ğ¾Ñ€Ğ½Ñ‹Ğµ Ğ¾Ğ³Ñ€Ğ°Ğ½Ğ¸Ñ‡ĞµĞ½Ğ¸Ñ** | High | High | ĞŸĞ¾Ğ·Ğ¸Ñ†Ğ¸Ğ¾Ğ½Ğ¸Ñ€Ğ¾Ğ²Ğ°Ğ½Ğ¸Ğµ wellness â‰  medicine, Ğ´Ğ¸ÑĞºĞ»ĞµĞ¹Ğ¼ĞµÑ€Ñ‹ Ğ²ĞµĞ·Ğ´Ğµ |
| **Data security breach** | Medium | Critical | E2E encryption, 152-Ğ¤Ğ— compliance, SOC2 prep |
| **AI Ğ³Ğ°Ğ»Ğ»ÑÑ†Ğ¸Ğ½Ğ°Ñ†Ğ¸Ğ¸** | Medium | High | RAG Ñ Ğ½Ğ°ÑƒÑ‡Ğ½Ñ‹Ğ¼Ğ¸ Ğ±Ğ°Ğ·Ğ°Ğ¼Ğ¸, Safety Agent, human-in-the-loop |
| **ĞĞ¸Ğ·ĞºĞ°Ñ ĞºĞ¾Ğ½Ğ²ĞµÑ€ÑĞ¸Ñ Freeâ†’Paid** | High | Medium | Value demonstration, trial, gamification |
| **API dependency (wearables)** | Medium | Medium | Multi-vendor strategy, caching, offline mode |
| **ĞšĞ¾Ğ½ĞºÑƒÑ€ĞµĞ½Ñ†Ğ¸Ñ BigTech** | High | High | Ğ¤Ğ¾ĞºÑƒÑ Ğ½Ğ° advanced users, RU market, deep personalization |

---

## Constraints

### Ğ¢ĞµÑ…Ğ½Ğ¸Ñ‡ĞµÑĞºĞ¸Ğµ Ğ¾Ğ³Ñ€Ğ°Ğ½Ğ¸Ñ‡ĞµĞ½Ğ¸Ñ

- **152-Ğ¤Ğ— compliance:** Ğ¥Ñ€Ğ°Ğ½ĞµĞ½Ğ¸Ğµ Ğ¿ĞµÑ€ÑĞ¾Ğ½Ğ°Ğ»ÑŒĞ½Ñ‹Ñ… Ğ´Ğ°Ğ½Ğ½Ñ‹Ñ… Ğ² Ğ Ğ¤
- **LLM latency:** ĞÑ‚Ğ²ĞµÑ‚ AI-Ğ°Ğ³ĞµĞ½Ñ‚Ğ° < 5 ÑĞµĞºÑƒĞ½Ğ´
- **API rate limits:** Wearables APIs Ğ¸Ğ¼ĞµÑÑ‚ Ğ»Ğ¸Ğ¼Ğ¸Ñ‚Ñ‹

### Ğ‘Ğ¸Ğ·Ğ½ĞµÑ-Ğ¾Ğ³Ñ€Ğ°Ğ½Ğ¸Ñ‡ĞµĞ½Ğ¸Ñ

- **Wellness â‰  Medicine:** ĞĞ• ÑÑ‚Ğ°Ğ²Ğ¸Ğ¼ Ğ´Ğ¸Ğ°Ğ³Ğ½Ğ¾Ğ·Ñ‹, ĞĞ• Ğ·Ğ°Ğ¼ĞµĞ½ÑĞµĞ¼ Ğ²Ñ€Ğ°Ñ‡Ğ°
- **Ğ­Ñ‚Ğ¸Ñ‡ĞµÑĞºĞ¸Ğµ Ğ³Ñ€Ğ°Ğ½Ğ¸Ñ†Ñ‹:** No dangerous protocols, no children, no pregnancy without MD
- **Ğ‘ÑĞ´Ğ¶ĞµÑ‚ MVP:** Limited runway â†’ Telegram-first approach

### Ğ ĞµĞ³ÑƒĞ»ÑÑ‚Ğ¾Ñ€Ğ½Ñ‹Ğµ Ğ¾Ğ³Ñ€Ğ°Ğ½Ğ¸Ñ‡ĞµĞ½Ğ¸Ñ

- Ğ—Ğ°Ğ¿Ñ€ĞµÑ‚ Ğ½Ğ° Ğ¼ĞµĞ´Ğ¸Ñ†Ğ¸Ğ½ÑĞºĞ¸Ğµ Ğ´Ğ¸Ğ°Ğ³Ğ½Ğ¾Ğ·Ñ‹ Ğ±ĞµĞ· Ğ»Ğ¸Ñ†ĞµĞ½Ğ·Ğ¸Ğ¸
- ĞĞ±ÑĞ·Ğ°Ñ‚ĞµĞ»ÑŒĞ½Ñ‹Ğµ Ğ´Ğ¸ÑĞºĞ»ĞµĞ¹Ğ¼ĞµÑ€Ñ‹ Ğ² Ñ€ĞµĞºĞ¾Ğ¼ĞµĞ½Ğ´Ğ°Ñ†Ğ¸ÑÑ…
- ĞĞ³Ñ€Ğ°Ğ½Ğ¸Ñ‡ĞµĞ½Ğ¸Ñ Ğ½Ğ° Ñ€ĞµĞºĞ»Ğ°Ğ¼Ñƒ Ğ¼ĞµĞ´Ğ¸Ñ†Ğ¸Ğ½ÑĞºĞ¸Ñ… ÑƒÑĞ»ÑƒĞ³

---

## Strategic Decisions (Ğ—Ğ°Ñ„Ğ¸ĞºÑĞ¸Ñ€Ğ¾Ğ²Ğ°Ğ½Ñ‹)

| ID | Decision | Rationale | Date |
|----|----------|-----------|------|
| **DEC-001** | Platform priority: Telegram Bot â†’ WebApp â†’ Mobile | Ğ‘Ñ‹ÑÑ‚Ñ€Ñ‹Ğ¹ time-to-market, validation hypothesis | 2026-01-26 |
| **DEC-002** | Target market: Ğ Ğ¾ÑÑĞ¸Ñ (primary) | 152-Ğ¤Ğ— Ğ³Ğ¾Ñ‚Ğ¾Ğ²Ğ½Ğ¾ÑÑ‚ÑŒ, Ğ»Ğ¾ĞºĞ°Ğ»ÑŒĞ½Ñ‹Ğµ Ğ»Ğ°Ğ±Ğ¾Ñ€Ğ°Ñ‚Ğ¾Ñ€Ğ¸Ğ¸, Ğ¿Ğ¾Ğ½ÑÑ‚Ğ½Ñ‹Ğ¹ Ñ€Ñ‹Ğ½Ğ¾Ğº | 2026-01-26 |
| **DEC-003** | MVP scope: Max modules + 1 integration each | Ğ”ĞµĞ¼Ğ¾Ğ½ÑÑ‚Ñ€Ğ°Ñ†Ğ¸Ñ Ğ¿Ğ¾Ğ»Ğ½Ğ¾Ñ‚Ñ‹ Ğ¿Ğ»Ğ°Ñ‚Ñ„Ğ¾Ñ€Ğ¼Ñ‹, validation Ğ²ÑĞµÑ… Ğ½Ğ°Ğ¿Ñ€Ğ°Ğ²Ğ»ĞµĞ½Ğ¸Ğ¹ | 2026-01-26 |
| **DEC-004** | LLM: GigaChat primary, YandexGPT fallback | Ğ Ğ¾ÑÑĞ¸Ğ¹ÑĞºĞ°Ñ Ğ»Ğ¾ĞºĞ°Ğ»Ğ¸Ğ·Ğ°Ñ†Ğ¸Ñ, 152-Ğ¤Ğ—, ÑÑ‚Ğ¾Ğ¸Ğ¼Ğ¾ÑÑ‚ÑŒ | 2026-01-26 |
| **DEC-005** | Infrastructure: Self-hosted Kubernetes | ĞšĞ¾Ğ½Ñ‚Ñ€Ğ¾Ğ»ÑŒ Ğ½Ğ°Ğ´ Ğ´Ğ°Ğ½Ğ½Ñ‹Ğ¼Ğ¸, compliance, Ğ³Ğ¸Ğ±ĞºĞ¾ÑÑ‚ÑŒ | 2026-01-26 |

---

## Vision Success Criteria

Vision ÑÑ‡Ğ¸Ñ‚Ğ°ĞµÑ‚ÑÑ Ñ€ĞµĞ°Ğ»Ğ¸Ğ·Ğ¾Ğ²Ğ°Ğ½Ğ½Ğ¾Ğ¹, ĞºĞ¾Ğ³Ğ´Ğ°:

- [ ] **10,000+ MAU** Ğ¸ÑĞ¿Ğ¾Ğ»ÑŒĞ·ÑƒÑÑ‚ AI-Ğ°Ğ³ĞµĞ½Ñ‚Ğ¾Ğ² Ğ´Ğ»Ñ Ñ€ĞµÑˆĞµĞ½Ğ¸Ğ¹ Ğ¾ Ğ·Ğ´Ğ¾Ñ€Ğ¾Ğ²ÑŒĞµ
- [ ] **60%+ Ğ¿Ğ¾Ğ»ÑŒĞ·Ğ¾Ğ²Ğ°Ñ‚ĞµĞ»ĞµĞ¹** Ğ¾Ñ‚Ğ¼ĞµÑ‡Ğ°ÑÑ‚ ÑƒĞ»ÑƒÑ‡ÑˆĞµĞ½Ğ¸Ğµ Health Score Ğ·Ğ° 3 Ğ¼ĞµÑÑÑ†Ğ°
- [ ] **40%+ Ğ¿Ğ¾Ğ»ÑŒĞ·Ğ¾Ğ²Ğ°Ñ‚ĞµĞ»ĞµĞ¹** Ğ¿Ñ€Ğ¾Ğ²ĞµĞ»Ğ¸ Ñ…Ğ¾Ñ‚Ñ Ğ±Ñ‹ 1 N=1 ÑĞºÑĞ¿ĞµÑ€Ğ¸Ğ¼ĞµĞ½Ñ‚
- [ ] **NPS â‰¥ 50** ÑÑ€ĞµĞ´Ğ¸ Ğ¿Ğ»Ğ°Ñ‚ÑÑ‰Ğ¸Ñ… Ğ¿Ğ¾Ğ»ÑŒĞ·Ğ¾Ğ²Ğ°Ñ‚ĞµĞ»ĞµĞ¹
- [ ] **$50K+ MRR** Ğ² Ñ‚ĞµÑ‡ĞµĞ½Ğ¸Ğµ 12 Ğ¼ĞµÑÑÑ†ĞµĞ²

---

## Next Steps

1. **PRD** â†’ Ğ”ĞµÑ‚Ğ°Ğ»Ğ¸Ğ·Ğ°Ñ†Ğ¸Ñ Ñ‚Ñ€ĞµĞ±Ğ¾Ğ²Ğ°Ğ½Ğ¸Ğ¹ Ğ¿Ğ¾ ĞºĞ°Ğ¶Ğ´Ğ¾Ğ¼Ñƒ Ğ¼Ğ¾Ğ´ÑƒĞ»Ñ
2. **Personas** â†’ Ğ“Ğ»ÑƒĞ±Ğ¾ĞºĞ¸Ğµ Ğ¿Ñ€Ğ¾Ñ„Ğ¸Ğ»Ğ¸ Ñ JTBD Ğ¸ ÑÑ†ĞµĞ½Ğ°Ñ€Ğ¸ÑĞ¼Ğ¸
3. **Market Research** â†’ TAM/SAM/SOM, Ñ†ĞµĞ½Ğ¾Ğ¾Ğ±Ñ€Ğ°Ğ·Ğ¾Ğ²Ğ°Ğ½Ğ¸Ğµ, Ñ‚Ñ€ĞµĞ½Ğ´Ñ‹
4. **Business Model** â†’ Ğ”ĞµÑ‚Ğ°Ğ»Ğ¸Ğ·Ğ°Ñ†Ğ¸Ñ revenue streams Ğ¸ unit economics

---

## References

- Research Document: `docs/BIOMAX_AI_v2_Extended_Research (1).md`
- Project Brief: `context/project-brief.yaml`
- Competitive Analysis: `docs/discovery/competitive-analysis.md`
- User Stories: `docs/discovery/user-stories.md`

---

*Ğ”Ğ¾ĞºÑƒĞ¼ĞµĞ½Ñ‚ ÑĞ¾Ğ·Ğ´Ğ°Ğ½: 2026-01-26*  
*Product Agent v1.0*
